Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Are there opportunities for a closer collaboration on clinical stroke research in Europe?

Berge E, Ford GA, Stapf C, Al-Shahi Salman R, Fischer U, Coveney S, Weimar C, Arnold M, Arsovska A, Lemmens R, Nederkoorn PJ, Kelly PJ.

Eur Stroke J. 2018 Mar;3(1):22-28. doi: 10.1177/2396987317747456. Epub 2017 Dec 11.

2.

Comparison of source localization techniques in diffuse optical tomography for fNIRS application using a realistic head model.

Tremblay J, Martínez-Montes E, Vannasing P, Nguyen DK, Sawan M, Lepore F, Gallagher A.

Biomed Opt Express. 2018 Jun 7;9(7):2994-3016. doi: 10.1364/BOE.9.002994. eCollection 2018 Jul 1.

3.

Transcriptomic Analysis of Zebrafish TDP-43 Transgenic Lines.

Lissouba A, Liao M, Kabashi E, Drapeau P.

Front Mol Neurosci. 2018 Dec 13;11:463. doi: 10.3389/fnmol.2018.00463. eCollection 2018.

4.

Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis.

Medrano S, Abdel-Baki A, Stip E, Potvin S.

Psychopharmacol Bull. 2018 Jun 20;48(4):25-61.

5.

Effects of high intensity interval training among overweight individuals with psychotic disorders: A randomized controlled trial.

Romain AJ, Fankam C, Karelis AD, Letendre E, Mikolajczak G, Stip E, Abdel-Baki A.

Schizophr Res. 2019 Aug;210:278-286. doi: 10.1016/j.schres.2018.12.021. Epub 2018 Dec 28.

PMID:
30595443
6.

Diverse Electronic and Magnetic Properties of Chlorination-Related Graphene Nanoribbons.

Nguyen DK, Tran NTT, Nguyen TT, Lin MF.

Sci Rep. 2018 Dec 14;8(1):17859. doi: 10.1038/s41598-018-35627-6.

7.

Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies.

International League Against Epilepsy Consortium on Complex Epilepsies.

Nat Commun. 2018 Dec 10;9(1):5269. doi: 10.1038/s41467-018-07524-z.

8.

Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43.

Bose P, Armstrong GAB, Drapeau P.

J Neurophysiol. 2019 Jan 1;121(1):285-297. doi: 10.1152/jn.00265.2018. Epub 2018 Nov 21.

PMID:
30461368
9.

The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada.

Bruneau J, Arruda N, Zang G, Jutras-Aswad D, Roy É.

Addiction. 2019 Feb;114(2):366-373. doi: 10.1111/add.14487. Epub 2018 Dec 9.

PMID:
30399197
10.

Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level.

Riché R, Liao M, Pena IA, Leung KY, Lepage N, Greene NDE, Sarafoglou K, Schimmenti LA, Drapeau P, Samarut É.

JCI Insight. 2018 Nov 2;3(21). pii: 124642. doi: 10.1172/jci.insight.124642.

11.

Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.

Tétreault M, Deshaies JE, Semmler S, Sidibé H, Shkreta L, Volkening K, Soreq H, Strong MJ, Chabot B, Vande Velde C.

Brain. 2018 Dec 1;141(12):e84. doi: 10.1093/brain/awy261. No abstract available.

PMID:
30364932
12.
13.

Bispectrum Features and Multilayer Perceptron Classifier to Enhance Seizure Prediction.

Bou Assi E, Gagliano L, Rihana S, Nguyen DK, Sawan M.

Sci Rep. 2018 Oct 19;8(1):15491. doi: 10.1038/s41598-018-33969-9.

14.

Treatment Adherence in Young Adults Receiving Kidney Replacement Therapy: A Caregiver Perspective.

Duquette P, Helm K.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1615-1616. doi: 10.2215/CJN.11200918. Epub 2018 Oct 16. No abstract available.

PMID:
30327295
15.

γ-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment.

Samarut É, Swaminathan A, Riché R, Liao M, Hassan-Abdi R, Renault S, Allard M, Dufour L, Cossette P, Soussi-Yanicostas N, Drapeau P.

Epilepsia. 2018 Nov;59(11):2061-2074. doi: 10.1111/epi.14576. Epub 2018 Oct 15.

PMID:
30324621
16.

Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS.

Martineau É, Di Polo A, Vande Velde C, Robitaille R.

Elife. 2018 Oct 15;7. pii: e41973. doi: 10.7554/eLife.41973.

17.

EGFL7 - a potential therapeutic target for multiple sclerosis?

Uphaus T, Zipp F, Larochelle C.

Expert Opin Ther Targets. 2018 Nov;22(11):899-902. doi: 10.1080/14728222.2018.1535595. Epub 2018 Oct 17. No abstract available.

PMID:
30312112
18.

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.

Lorscheider J, Kuhle J, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Hupperts R, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Sola P, Ferraro D, Trojano M, Ramo-Tello C, Lechner-Scott J, Pucci E, Solaro C, Slee M, Van Pesch V, Sanchez Menoyo JL, van der Walt A, Butzkueven H, Kappos L, Kalincik T; MSBase Study Group.

Eur J Neurol. 2019 Feb;26(2):363-370. doi: 10.1111/ene.13824. Epub 2018 Nov 2.

PMID:
30298572
19.

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis.

Min M, Spelman T, Lugaresi A, Boz C, Spitaleri D, Pucci E, Grand'Maison F, Granella F, Izquierdo G, Butzkueven H, Sanchez-Menoyo JL, Barnett M, Girard M, Trojano M, Grammond P, Duquette P, Sola P, Alroughani R, Hupperts R, Vucic S, Kalincik T, Van Pesch V, Lechner-Scott J.

Mult Scler. 2018 Oct;24(12):1569-1577. doi: 10.1177/1352458518798147. Epub 2018 Sep 20.

PMID:
30234431
20.

Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry.

Tourjman SV, Potvin S, Corbalan F, Djouini A, Purdon SE, Stip E, Juster RP, Kouassi E.

Atten Defic Hyperact Disord. 2019 Jun;11(2):139-147. doi: 10.1007/s12402-018-0268-7. Epub 2018 Sep 17.

PMID:
30225804

Supplemental Content

Loading ...
Support Center